Bradfordhill (Site 0702)

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Cervical cancer1 trial

Phase

• Phase 11 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Merck Sharp & Dohme LLC2 trials

Running trials

• Recruiting

  A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

  NCT07216703· Phase 3· Merck Sharp & Dohme LLC· Source

  Contact: Study Coordinator

• Active, not recruiting

  Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)

  NCT05853367· Phase 1· Merck Sharp & Dohme LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Cervical cancer1 recruiting